| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000257808.1 |
Ponatinib |
Breast invasive carcinoma |
0.03875429 |
Resistant |
| ENSG00000257808.1 |
Ponatinib |
Sarcoma |
0.008497158 |
Sensitive |
| ENSG00000257808.1 |
Ponatinib |
Brain lower grade glioma |
0.024813171 |
Resistant |
| ENSG00000257808.1 |
Ponatinib |
Skin cutaneous melanoma |
0.007736985 |
Sensitive |
